Abstract:We demonstrate a novel approach to enhance the precision of surgical needle shape tracking based on distributed strain sensing using optical frequency domain reflectometry (OFDR). The precision enhancement is provided by using optical fibers with high scattering properties. Shape tracking of surgical tools using strain sensing properties of optical fibers has seen increased attention in recent years. Most of the investigations made in this field use fiber Bragg gratings (FBG), which can be used as discrete or quasi-distributed strain sensors. By using a truly distributed sensing approach (OFDR), preliminary results show that the attainable accuracy is comparable to accuracies reported in the literature using FBG sensors for tracking applications (~1mm). We propose a technique that enhanced our accuracy by 47% using UV exposed fibers, which have higher light scattering compared to un-exposed standard single mode fibers. Improving the experimental setup will enhance the accuracy provided by shape tracking using OFDR and will contribute significantly to clinical applications. Symposium, 2000 IEEE, 2000, pp. 1601-1604. 6. N. D. Inc, (2016, 15 Janvier 2016. Medical Aurora -Medical.Available: http://www.ndigital.com/medical/products/aurora/ 7. T. Bien, M. Li, Z. Salah, and G. Rose, "Electromagnetic tracking system with reduced distortion using quadratic excitation," Int. J. CARS 9(2), 323-332 (2014 387-398 (2014).
Cancer therapy has evolved to a more targeted approach and often involves drug combinations to achieve better response rates. Non-thermal plasma (NTP), a technology rapidly expanding its application in the medical field, is a near room temperature ionized gas capable of producing reactive species, and can induce cancer cell death both in vitro and in vivo. Here, we used proliferation assay to characterize the plasma sensitivity of fourteen breast cancer cell lines. These assays showed that all tested cell lines were sensitive to NTP. In addition, a good correlation was found comparing cell sensitivity to NTP and radiation therapy (RT), where cells that were sensitive to RT were also sensitive to plasma. Moreover, in some breast cancer cell lines, NTP and RT have a synergistic effect. Adding a dose of PARP-inhibitor olaparib to NTP treatment always increases the efficacy of the treatment. Olaparib also exhibits a synergistic effect with NTP, especially in triple negative breast cancer cells. Results presented here help elucidate the position of plasma use as a potential breast cancer treatment.
Diffuse dielectric barrier discharges in atmospheric-pressure helium can be sustained over a wide range of excitation frequencies (from, but not restricted, 25 kHz to 15 MHz). The aim of the present paper is to identify the specific characteristics of the discharge modes that can be sustained in this frequency range, namely, the atmospheric-pressure Townsend-like discharge (APTD-L) mode, the atmospheric-pressure glow discharge (APGD) mode, the Ω mode, the hybrid mode, and the RF-α mode. This is achieved experimentally, by measuring the density of helium metastable atoms, which are known to play a driving role on the discharge kinetics. This density is measured by means of two absorption spectroscopy methods, one using a spectral lamp and the other one using a diode laser as a light source. The first one provides the time-averaged atom densities in the singlet He(21S) and triplet He(23S) metastable states, while with the second one we access the time-resolved density of He(23S) atoms. Time-averaged measurements indicate that the He(23S) density is relatively low in the APTD-L, the Ω and the RF-α modes (<4×1016 m−3) slightly higher in the APGD mode (2–7×1016 m−3), and still higher (>1×1017 m−3) in the hybrid mode. The hybrid mode is exclusively observed for frequencies from 0.2 to 3 MHz. However, time-resolved density measurement shows that at 1 MHz and below, the hybrid mode is not continuously sustained. Instead, the discharge oscillates between the Ω and the hybrid mode with a switching frequency about the kilohertz. This explains the significantly lower power required to sustain the plasma as compared to above 1 MHz.
Radiotherapy (RT) is a key component of cancer treatment. Most of the time, radiation is given after surgery but for soft-tissue sarcomas (STS), pre-surgical radiation is commonly utilized. However, despite improvements in RT accuracy, the rate of local recurrence remains high and is the major cause of death for patients with STS. A better understanding of cell fates in response to RT could provide new therapeutic options to enhance tumour cell killing by RT and facilitate surgical resection. Here, we showed that irradiated STS cell cultures do not die but instead undergo therapy-induced senescence (TIS), which is characterized by proliferation arrest, senescence-associated β-galactosidase activity, secretion of inflammatory cytokines and persistent DNA damage. STS-TIS was also associated with increased levels of the anti-apoptotic Bcl-2 family of proteins which rendered cells targetable using senolytic Bcl-2 inhibitors. As oppose to radiation alone, the addition of senolytic agents Venetoclax (ABT-199) or Navitoclax (ABT-263) after irradiation induced a rapid apoptotic cell death in STS monolayer cultures and in a more complex three-dimensional culture model. Together, these data suggest a new promising therapeutic approach for sarcoma patients who receive neoadjuvant RT. The addition of senolytic agents to radiation treatments may significantly reduce tumour volume prior to surgery and thereby improve the clinical outcome of patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.